Eevia Health Plc exhibiting at an essential Nutraceutical tradeshow
Eevia Health Plc (”Eevia” or ”The Company”) is promoting its products and value proposition by exhibiting at Vitafoods 2024, an essential nutraceutical tradeshow held in Geneva, Switzerland, between 14 – 16 May 2023.
This week, Eevia is at the annual Vitafoods Nutraceuticals tradeshow (https://www.vitafoods.eu.com) in Geneva. Vitafoods is a key event in the global nutraceutical industry, attracting over 16,000 industry experts from over 130 countries every year. The show has a leading position in the industry by maintaining a strong focus and high quality, including an extensive seminar program adjacent to the tradeshow floor.
«Eevia has received strong customer feedback on our recent research article comparing the company’s proprietary Fenoprolic® with the market-leading pine bark extract. The article showed a nearly identical bioactivity profile. The new data resulted in several serious discussions with prospects for the use of Fenoprolic® as an active ingredient in their supplements, and we expect some very nice starting orders at the show or soon after that,” states Anna-Maija Vanhatalo, Eevia’s sales manager for Europe.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
